{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:38:37Z","timestamp":1782419917363,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03405-1","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T05:16:49Z","timestamp":1737695809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of sulfasalazine on recurrent acute anterior uveitis: a three-year follow-up"],"prefix":"10.1007","volume":"45","author":[{"given":"Ana","family":"Avello-Gorostidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Hernanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Robles-Barrena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Olivas-Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo E.","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Arconada-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredeswinda","family":"Romero-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"S\u00e1nchez-Pernaute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"3405_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"Standardization of Uveitis Nomenclature for Reporting Clinical Data","year":"2005","unstructured":"Standardization of Uveitis Nomenclature for Reporting Clinical Data (2005) Results of the first international workshop. Am J Ophthalmol 140:509\u2013516","journal-title":"Am J Ophthalmol"},{"key":"3405_CR2","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00417-018-4082-x","volume":"256","author":"MM Zu Hoerste","year":"2018","unstructured":"Zu Hoerste MM, Walscheid K, Tappeiner C, Zurek-Imhoff B, Heinz C, Heiligenhaus A (2018) The effect of methotrexate and sulfasalazine on the course of HLA-B27-positive anterior uveitis: results from a retrospective cohort study. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 256:1985\u20131992","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"3405_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1600-0420.1995.tb00040.x","volume":"73","author":"KM Saari","year":"1995","unstructured":"Saari KM, P\u00e4iv\u00f6nsalo-Hietanen T, Vaahtoranta-Lehtonen H, Tuominen J, Sillanp\u00e4\u00e4 M (1995) Epidemiology of endogenous uveitis in south-western Finland. Acta Ophthalmol Scand 73:345\u2013349","journal-title":"Acta Ophthalmol Scand"},{"key":"3405_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/09286586.2020.1815802","volume":"28","author":"A Garc\u00eda-Aparicio","year":"2021","unstructured":"Garc\u00eda-Aparicio A, Alonso Mart\u00edn L, L\u00f3pez Lancho R, Quir\u00f3s Zamorano R, Del Olmo PL, S\u00e1nchez Fern\u00e1ndez S et al (2021) Epidemiology of uveitis in a spanish region: prevalence and etiology. Ophthalmic Epidemiol 28:227\u2013236","journal-title":"Ophthalmic Epidemiol"},{"issue":"2","key":"3405_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/09273948.2010.542269","volume":"19","author":"D Wakefield","year":"2011","unstructured":"Wakefield D, Chang JH, Amjadi S, Maconochie Z, El-Asrar AA, McCluskey P (2011) What is new HLA-B27 acute anterior uveitis? Ocular Immunol Inflamm 19(2):139\u2013144. https:\/\/doi.org\/10.3109\/09273948.2010.542269","journal-title":"Ocular Immunol Inflamm"},{"key":"3405_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008045","volume":"96","author":"A G\u00f3mez-G\u00f3mez","year":"2017","unstructured":"G\u00f3mez-G\u00f3mez A, Loza E, Rosario MP, Espinosa G, de Morales JMGR, Herreras JM et al (2017) Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis. Medicine (Baltimore) 96:e8045","journal-title":"Medicine (Baltimore)"},{"key":"3405_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1517\/14728214.2011.537824","volume":"16","author":"T Larson","year":"2011","unstructured":"Larson T, Nussenblatt RB, Sen HN (2011) Emerging drugs for uveitis. Expert Opin Emerg Drugs 16:309\u2013322","journal-title":"Expert Opin Emerg Drugs"},{"key":"3405_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.farma.2022.12.005","volume":"47","author":"O Ibarra Barrueta","year":"2023","unstructured":"Ibarra Barrueta O, Garc\u00eda Mart\u00edn E, L\u00f3pez S\u00e1nchez P, Ram\u00edrez Herr\u00e1iz E, Merino Boh\u00f3rquez V, Ais LA (2023) Medicamentos inmunosupresores y biol\u00f3gicos en el embarazo, la lactancia y la fertilidad en enfermedades inmunomediadas. Farm Hosp 47:39\u201349","journal-title":"Farm Hosp"},{"key":"3405_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-3-540-75387-2_30","volume-title":"Intraocular Inflammation","author":"N St\u00fcbiger","year":"2016","unstructured":"St\u00fcbiger N (2016) Sulfasalazine. In: Zierhut M, Pavesio C, Ohno S, Orefice F, Rao NA (eds) Intraocular Inflammation. Springer Berlin Heidelberg, Berlin, Heidelberg, pp 373\u2013377. https:\/\/doi.org\/10.1007\/978-3-540-75387-2_30"},{"key":"3405_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230560","volume":"15","author":"N Bouzid","year":"2020","unstructured":"Bouzid N, Jamilloux Y, Chapurlat R, Pradat P, De Parisot A, Kodjikian L et al (2020) Impact of systemic treatments on the course of HLA-B27-associated uveitis: a retrospective study of 101 patients. PLoS ONE 15:e0230560","journal-title":"PLoS ONE"},{"issue":"Pt 3A","key":"3405_CR11","first-page":"340","volume":"14","author":"JM Benitez-Del-Castillo","year":"2000","unstructured":"Benitez-Del-Castillo JM, Garcia-Sanchez J, Iradier T, Ba\u00f1ares A (2000) Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye Lond Engl 14(Pt 3A):340\u2013343","journal-title":"Eye Lond Engl"},{"key":"3405_CR12","first-page":"1277","volume":"30","author":"S Mu\u00f1oz-Fern\u00e1ndez","year":"2003","unstructured":"Mu\u00f1oz-Fern\u00e1ndez S, Hidalgo V, Fern\u00e1ndez-Mel\u00f3n J, Schlincker A, Bonilla G, Ruiz-Sancho D et al (2003) Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period. J Rheumatol 30:1277\u20131279","journal-title":"J Rheumatol"},{"issue":"60","key":"3405_CR13","first-page":"81","volume":"1993","author":"M Dougados","year":"1993","unstructured":"Dougados M, Berenbaum F, Maetzel A, Amor B (1993) Prevention of acute anterior uveitis associated with spondylarthropathy induced by salazosulfapyridine. Rev Rhum Ed Francaise 1993(60):81\u201383","journal-title":"Rev Rhum Ed Francaise"},{"key":"3405_CR14","unstructured":"Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS March 31, 2003 (http:\/\/ctep.cancer.gov), Publish Date: August 9, 2006 [Internet]. 2006 [cited 2024 May 11]. Available from: http:\/\/ctep.cancer.gov"},{"key":"3405_CR15","unstructured":"Salazopyrina 500 mg comprimidos. Ficha t\u00e9cnica. [Internet]. Pfizer SL. 2022 [cited 2023 Dec 30]. Available from: https:\/\/cima.aemps.es\/cima\/pdfs\/es\/ft\/39681\/FT_39681.html.pdf"},{"key":"3405_CR16","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/ard.2008.092585","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, R\u00f8devand E, Holck P, Vanhoof J, Kron M, Kary S et al (2009) Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis 68:696\u2013701","journal-title":"Ann Rheum Dis"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03405-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03405-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03405-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:06:15Z","timestamp":1766167575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03405-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3405"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03405-1","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"14 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval along with an informed consent waiver was granted by the reference clinical research ethic committee at the University Hospital Fundaci\u00f3n Jimenez Diaz (Madrid, Spain).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"36"}}